SPONSORED CONTENT
Trademark registration service includes:
- Trademark attorney managed
- Federal trademark search
- Apply online - fast & easy
- Electronic filing of application
- You are always kept informed
Vaccines; Anti-infectives; Pharmaceutical preparations for the treatment of damaged skin and tissue, pain, inflammation, obesity, and infectious diseases; Pharmaceutical preparations for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, oncological, hepatological, hematological, bacterial, respiratory, neurological, gastrointestinal, dermatological, psychiatric, and immune system ...
Status Alert: On Wednesday, March 26, 2025, the status for the HILBRENZY mark changed to NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER .
On Wednesday, March 26, 2025, a U.S federal trademark application was filed for HILBRENZY by Glaxo Group Limited, GSK Medicines Research Centre, Gunnels Wood Road, Stevenage. The USPTO has assigned the HILBRENZY mark the serial number 99104822. The HILBRENZY mark has been filed in the category Pharmaceutical Products. The owner of the HILBRENZY mark is listed as Glaxo Group Limited, GSK Medicines Research Centre, Gunnels Wood Road, Stevenage. The correspondent for the HILBRENZY mark is Christopher M. Hanes GSK of 410 Blackwell Street, Durham, NC 27701, United States. If you have licensing, usage or other questions concerning the HILBRENZY mark, please contact the owner through the listed correspondent. The description provided for the HILBRENZY mark is Vaccines; Anti-infectives; Pharmaceutical preparations for the treatment of damaged skin and tissue, pain, inflammation, obesity, and infectious diseases; Pharmaceutical preparations for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, oncological, hepatological, hematological, bacterial, respiratory, neurological, gastrointestinal, dermatological, psychiatric, and immune system ... |
|
Word Mark: | HILBRENZY |
Status: | NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER |
Status Date: | 03/26/2025 |
Serial Number: | 99104822 |
Filing Date: | 03/26/2025 |
Registration Number: | Not Available |
Registration Date: | Not Available |
Goods and Services: | Vaccines; Anti-infectives; Pharmaceutical preparations for the treatment of damaged skin and tissue, pain, inflammation, obesity, and infectious diseases; Pharmaceutical preparations for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, oncological, hepatological, hematological, bacterial, respiratory, neurological, gastrointestinal, dermatological, psychiatric, and immune system related diseases and disorders; Pharmaceutical preparations for the prevention of infectious diseases |
Type Of Mark: | Trademark |
Register Type: | Principal |
Published For Opposition Date: | Not Available |
Current Owner: | Glaxo Group Limited GSK Medicines Research Centre Gunnels Wood Road Stevenage SG12NY UNITED KINGDOM |
Mark Description: | Not Available |
Mark Drawing Type: | Not Available |
Design Search: | Not Available |
Disclaimer: | Not Available |
Correspondent: | Christopher M. Hanes GSK 410 Blackwell Street Durham, NC 27701 United States |
International Class(es): | 005 |
US Class(es): | 005, 006, 018, 044, 046, 051, 052 |
Primary Class: | Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
Class(es) Status: | Active |
First Use Anywhere: | Not Available |
First Use In Commerce: | Not Available |
Retrieve Trademark Documents |